SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001567619-20-003780
Filing Date
2020-02-14
Accepted
2020-02-14 12:49:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 64690
  Complete submission text file 0001567619-20-003780.txt   66596
Mailing Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255
Business Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255 7043868486
BANK OF AMERICA CORP /DE/ (Filed by) CIK: 0000070858 (see all company filings)

IRS No.: 560906609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks

Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88976 | Film No.: 20617025
SIC: 2834 Pharmaceutical Preparations